Notice of New NIH Policy Manual 1311-Preventing and Addressing Harassment and Inappropriate Conduct and New Policy Statement on Inappropriate Relationships in the Workplace, 47634-47635 [2018-20505]
Download as PDF
<![CDATA[
amozie on DSK3GDR082PROD with NOTICES1
47634
Federal Register / Vol. 83, No. 183 / Thursday, September 20, 2018 / Notices
Individuals with Substance Use Disorder
(R61/R33 Clinical Trial Optional).
Date: October 3, 2018.
Time: 12:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Ipolia R. Ramadan, Ph.D.,
Scientific Review Officer, Office of
Extramural Policy and Review, Division of
Extramural Research, National Institute on
Drug Abuse, NIH, DHHS, 6001 Executive
Boulevard, Room 4228, MSC 9550, Bethesda,
MD 20892, 301–827–5842, ramadanir@
mail.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Exploring Epigenomic or Non-Coding RNA
Regulation in the Development,
Maintenance, or Treatment of Chronic Pain
(R61/R33 Clinical Trial Optional).
Date: October 12, 2018.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Ipolia R. Ramadan, Ph.D.,
Scientific Review Officer, Office of
Extramural Policy and Review, Division of
Extramural Research, National Institute on
Drug Abuse, NIH, DHHS, 6001 Executive
Boulevard, Room 4228, MSC 9550, Bethesda,
MD 20892, 301–827–5842, ramadanir@
mail.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Coordinating Center to Support NIDA Rural
Opioid HIV and Comorbidity Initiative
(U24—Clinical Trial Not Allowed).
Date: October 17, 2018.
Time: 2:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Hiromi Ono, Ph.D.,
Scientific Review Officer, Office of
Extramural Policy and Review, National
Institute on Drug Abuse, National Institutes
of Health, DHHS, 6001 Executive Boulevard,
Room 4238, MSC 9550, Bethesda, MD 20892,
301–827–5820, hiromi.ono@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: September 14, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
AGENCY:
[FR Doc. 2018–20423 Filed 9–19–18; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
18:01 Sep 19, 2018
Jkt 244001
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Institutional
Training Grants.
Date: October 17, 2018.
Time: 9:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Kimberly Firth, Ph.D.,
National Institutes of Health, National
Institute on Aging, Gateway Building, 7201
Wisconsin Avenue, Suite 2C212, Bethesda,
MD 20892, 301–402–7702, firthkm@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: September 14, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–20420 Filed 9–19–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of New NIH Policy Manual
1311—Preventing and Addressing
Harassment and Inappropriate
Conduct and New Policy Statement on
Inappropriate Relationships in the
Workplace
National Institutes of Health,
HHS.
ACTION:
Notice.
The National Institutes of
Health (NIH) announces Policy Manual
Chapter: 1311—Preventing and
SUMMARY:
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
Addressing Harassment and
Inappropriate Conduct and a new Policy
Statement addressing Personal
Relationships in the Workplace. These
policies apply to federal employees,
contractors, trainees, and fellows who
perform work for the NIH. The NIH
expects that organizations receiving NIH
funds have in place similarly rigorous
policies and related procedures for their
employees, contractors, trainees, and
fellows who engage in agency-funded
activities.
FOR FURTHER INFORMATION CONTACT: For
further information about these new
policies, contact Jessica Hawkins, Office
of Human Resources, National Institutes
of Health, Building 31, Room 1/B37,
Bethesda, Maryland 20892, telephone
301–402–8006 (not a toll-free number),
hawkinj@od.nih.gov.
SUPPLEMENTARY INFORMATION: Policy
Manual 1311—Preventing and
Addressing Harassment and
Inappropriate Conduct states that the
NIH will not tolerate inappropriate
conduct or harassment, including sexual
harassment. Timely and appropriate
action will be taken against any
individual found to be in violation of
the policy outlined in the Manual
Chapter. Through enforcement of this
policy, the NIH seeks to prevent,
correct, and eliminate unacceptable
behavior that is inconsistent with the
values and culture of respect and
inclusion. Further, the policy is
intended to increase the transparency
and consistency in how allegations of
harassment are reviewed and resolved.
NIH leadership has designated the
Office of Human Resources’ Civil
Program as the entity charged with
receiving allegations of harassment and
overseeing relevant administrative
inquiries.
The NIH Policy Statement on Personal
Relationships in the Workplace states
that personal relationships (including
romantic and/or sexual) between
individuals in inherently unequal
positions, where one party has real or
perceived authority over the other in
their professional roles, may be
inappropriate in the workplace and are
strongly discouraged. If such a
relationship exists or develops, it must
be disclosed. Upon such notification,
the responsible agency official must
insure that the NIH Institute/Center
manages, decreases, or eliminates
potential risk as a result of the
relationship.
This applies to all individuals in the
NIH community, including employees,
contractors, students, trainees, and
fellows and includes anyone who holds
a position of authority or perceived
E:\FR\FM\20SEN1.SGM
20SEN1
Federal Register / Vol. 83, No. 183 / Thursday, September 20, 2018 / Notices
authority over another individual from
a scientific or administrative
perspective.
Dated: September 17, 2018.
Francis S. Collins,
Director, National Institutes of Health.
[FR Doc. 2018–20505 Filed 9–19–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute Notice of
Closed Meetings
amozie on DSK3GDR082PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Innovative
Molecular and Cellular Analysis
Technologies (IMAT).
Date: October 19, 2018.
Time: 8:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
2E908, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Jeffrey E. DeClue, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W114, Bethesda, MD 20892–
9750, 240–276–5287, decluej@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Cancer
Systems Biology.
Date: November 1, 2018.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 5335 Wisconsin Ave. NW,
Washington, DC 20015.
Contact Person: Eun Ah Cho, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W124, Bethesda, MD
20892–9750, 240–276–6342, choe@
mail.nih.gov.
VerDate Sep<11>2014
18:01 Sep 19, 2018
Jkt 244001
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Investigation of the Transmission of Kaposi
Sarcoma-Associated Herpesvirus.
Date: November 14, 2018.
Time: 12:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
7W238, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Byeong-Chel Lee, Ph.D.,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W238, Bethesda, MD 20892–9750,
240–276–7755, byeong-chel.lee@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: September 14, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–20419 Filed 9–19–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Bioengineering
Sciences & Technologies Integrated Review
Group; Modeling and Analysis of Biological
Systems Study Section.
Date: October 18–19, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The William F. Bolger Center, 9600
Newbridge Drive, Potomac, MD 20854.
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
47635
Contact Person: Craig Giroux, Ph.D.,
Scientific Review Officer, BST IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5150,
Bethesda, MD 20892, 301–435–2204,
girouxcn@csr.nih.gov.
Name of Committee: Vascular and
Hematology Integrated Review Group;
Hemostasis and Thrombosis Study Section.
Date: October 18, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Bukhtiar H Shah, DVM,
Ph.D., Scientific Review Officer, Vascular
and Hematology IRG, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 4120, MSC 7802,
Bethesda, MD 20892, (301) 806–7314,
shahb@csr.nih.gov.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group;
Host Interactions with Bacterial Pathogens
Study Section.
Date: October 18–19, 2018.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Warwick Denver, 1776 Grant Street,
Denver, CO 80203.
Contact Person: Fouad A El-Zaatari, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3186,
MSC 7808, Bethesda, MD 20892, (301) 435–
1149, elzaataf@csr.nih.gov.
Name of Committee: Musculoskeletal, Oral
and Skin Sciences Integrated Review Group;
Oral, Dental and Craniofacial Sciences Study
Section.
Date: October 18–19, 2018.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Capital View, 2850
South Potomac Avenue, Arlington, VA
22202.
Contact Person: Yi-Hsin Liu, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4214,
MSC 7814, Bethesda, MD 20892, 301–435–
1781, liuyh@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Neurodevelopment, Synaptic
Plasticity and Neurodegeneration.
Date: October 18–19, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda,
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Mary Schueler, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5214,
MSC 7846, Bethesda, MD 20892, 301–451–
0996, marygs@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Fellowship:
Behavioral Neuroscience.
E:\FR\FM\20SEN1.SGM
20SEN1
]]>Agencies
[Federal Register Volume 83, Number 183 (Thursday, September 20, 2018)]
[Notices]
[Pages 47634-47635]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-20505]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of New NIH Policy Manual 1311--Preventing and Addressing
Harassment and Inappropriate Conduct and New Policy Statement on
Inappropriate Relationships in the Workplace
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The National Institutes of Health (NIH) announces Policy
Manual Chapter: 1311--Preventing and Addressing Harassment and
Inappropriate Conduct and a new Policy Statement addressing Personal
Relationships in the Workplace. These policies apply to federal
employees, contractors, trainees, and fellows who perform work for the
NIH. The NIH expects that organizations receiving NIH funds have in
place similarly rigorous policies and related procedures for their
employees, contractors, trainees, and fellows who engage in agency-
funded activities.
FOR FURTHER INFORMATION CONTACT: For further information about these
new policies, contact Jessica Hawkins, Office of Human Resources,
National Institutes of Health, Building 31, Room 1/B37, Bethesda,
Maryland 20892, telephone 301-402-8006 (not a toll-free number),
[email protected].
SUPPLEMENTARY INFORMATION: Policy Manual 1311--Preventing and
Addressing Harassment and Inappropriate Conduct states that the NIH
will not tolerate inappropriate conduct or harassment, including sexual
harassment. Timely and appropriate action will be taken against any
individual found to be in violation of the policy outlined in the
Manual Chapter. Through enforcement of this policy, the NIH seeks to
prevent, correct, and eliminate unacceptable behavior that is
inconsistent with the values and culture of respect and inclusion.
Further, the policy is intended to increase the transparency and
consistency in how allegations of harassment are reviewed and resolved.
NIH leadership has designated the Office of Human Resources' Civil
Program as the entity charged with receiving allegations of harassment
and overseeing relevant administrative inquiries.
The NIH Policy Statement on Personal Relationships in the Workplace
states that personal relationships (including romantic and/or sexual)
between individuals in inherently unequal positions, where one party
has real or perceived authority over the other in their professional
roles, may be inappropriate in the workplace and are strongly
discouraged. If such a relationship exists or develops, it must be
disclosed. Upon such notification, the responsible agency official must
insure that the NIH Institute/Center manages, decreases, or eliminates
potential risk as a result of the relationship.
This applies to all individuals in the NIH community, including
employees, contractors, students, trainees, and fellows and includes
anyone who holds a position of authority or perceived
[[Page 47635]]
authority over another individual from a scientific or administrative
perspective.
Dated: September 17, 2018.
Francis S. Collins,
Director, National Institutes of Health.
[FR Doc. 2018-20505 Filed 9-19-18; 8:45 am]
BILLING CODE 4140-01-P
